(Q36610478)

English

Tumor response evaluation criteria for HCC (hepatocellular carcinoma) treated using TACE (transcatheter arterial chemoembolization): RECIST (response evaluation criteria in solid tumors) version 1.1 and mRECIST (modified RECIST): JIVROSG-0602.

scientific article published on 20 November 2012

Statements

Tumor response evaluation criteria for HCC (hepatocellular carcinoma) treated using TACE (transcatheter arterial chemoembolization): RECIST (response evaluation criteria in solid tumors) version 1.1 and mRECIST (modified RECIST): JIVROSG-0602. (English)
Hirokazu Watanabe
Noriaki Sakamoto
Masahide Takahashi
Japan Interventional Radiology in Oncology Study Group-JIVROSG

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit